Trabecular microbypass as replacement therapy in pharmacologically controlled open-angle glaucoma patients

ABSTRACT Purpose: To assess the outcomes of the trabecular bypass as replacement therapy for medications in pharmacologically controlled vs. pharmacologically uncontrolled open-angle glaucoma patients. Methods: This was a retrospective study of eyes treated with first- (iStent) or second-generation (iStent inject) trabecular bypass. Group 1 consisted of eyes with pharmacologically controlled intraocular pressure 0.05). Complete success rates were significantly higher in Group 1 than in Group 2: for intraocular pressure